Abstract
The goal of tumor immunology is to understand the interactions between tumor cells and immune system, and ultimately to devise immune basedapproaches to fight cancer. We discuss here recent advances in tumor immunology and in the interaction between immunology and informatics that provide new perspectives for the development of cancer therapy. Cancer immunoprevention is a novel approach to cancer prevention through the use of vaccines and other immunological strategies to be applied before tumor onset. The efficacy of cancer immunoprevention has been demonstrated in several experimental systems, however, as frequently happens in novel approaches, cancer immunoprevention studies incorporate a large number of variables. We show here how a specifically designed lattice gas model can provide significant insight for the analysis of immune variables and the design of new biological experiments. A second approach that provides new perspectives in tumor immunology as the result of interactions between immunology and informatics is the use of DNA microarrays to investigate and monitor tumor-host relationships and modifications induced by immunopreventive and immunotherapeutic interventions.
Keywords: Cancer immunoprevention, systems biology, computational models, DNA microarrays, HER-2/neu
Current Bioinformatics
Title: Current Issues in Tumor Immunology
Volume: 5 Issue: 3
Author(s): Annalisa Astolfi, Pier-Luigi Lollini, Santo Motta and Francesco Pappalardo
Affiliation:
Keywords: Cancer immunoprevention, systems biology, computational models, DNA microarrays, HER-2/neu
Abstract: The goal of tumor immunology is to understand the interactions between tumor cells and immune system, and ultimately to devise immune basedapproaches to fight cancer. We discuss here recent advances in tumor immunology and in the interaction between immunology and informatics that provide new perspectives for the development of cancer therapy. Cancer immunoprevention is a novel approach to cancer prevention through the use of vaccines and other immunological strategies to be applied before tumor onset. The efficacy of cancer immunoprevention has been demonstrated in several experimental systems, however, as frequently happens in novel approaches, cancer immunoprevention studies incorporate a large number of variables. We show here how a specifically designed lattice gas model can provide significant insight for the analysis of immune variables and the design of new biological experiments. A second approach that provides new perspectives in tumor immunology as the result of interactions between immunology and informatics is the use of DNA microarrays to investigate and monitor tumor-host relationships and modifications induced by immunopreventive and immunotherapeutic interventions.
Export Options
About this article
Cite this article as:
Astolfi Annalisa, Lollini Pier-Luigi, Motta Santo and Pappalardo Francesco, Current Issues in Tumor Immunology, Current Bioinformatics 2010; 5 (3) . https://dx.doi.org/10.2174/157489310792006684
DOI https://dx.doi.org/10.2174/157489310792006684 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
5-Fluorouracil – Characteristics and Analytical Determination
Current Pharmaceutical Analysis Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Current Drug Metabolism RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells
Anti-Cancer Agents in Medicinal Chemistry Huntingtons Disease: New Frontiers for Molecular and Cell Therapy
Current Drug Targets New Potential Pharmaceutical Applications of Hypericum Species
Mini-Reviews in Medicinal Chemistry Transdermal Delivery of 5-Fluorouracil for Induced Ehrlich Ascites Carcinoma Tumor in Balb/c Mice and Pharmacokinetic Study
Recent Patents on Anti-Cancer Drug Discovery Studies of p53 Tumor Suppression Activity in Mouse Models
Current Genomics Mutant B-Raf Kinase Inhibitors as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Potential of a Novel SERM Ormeloxifene
Current Medicinal Chemistry Therapeutic Targeting of Apoptotic Pathways: Novel Aspects in Pancreatic Cancer
Current Pharmaceutical Biotechnology Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Current Cancer Drug Targets Jun Dimerization Protein 2: A Multifunctional Transcription Factor in Mammalian Cells
Current Genomics Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases
Current Pharmaceutical Biotechnology The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Current Drug Metabolism Targeting Basal-Like Breast Cancers
Current Drug Targets A Mechanistic Overview on Male Infertility and Germ Cell Cancers
Current Pharmaceutical Design The Implication of Platelet Activating Factor in Cancer Growth and Metastasis: Potent Beneficial Role of PAF-Inhibitors and Antioxidants
Infectious Disorders - Drug Targets The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment
Current Pharmaceutical Design Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Current Pharmaceutical Biotechnology